<p>Aligos Therapeutics Inc. has granted non-qualified stock options to purchase a total of 14,100 shares to newly hired employees as part of its 2024 Inducement Plan. The options have an exercise price equal to the closing price of Aligos’ common stock on the grant date. Vesting will occur over four years, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments, contingent on continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aligos Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9599356-en) on December 12, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

ALGS

<p>Aligos Therapeutics Inc. has granted non-qualified stock options to purchase 14,100 shares to new employees under its 2024 Inducement Plan. The options have an exercise price equal to the closing price on the grant date, with vesting over four years. This announcement was originally published by Aligos Therapeutics via GlobeNewswire on December 12, 2025.</p>

Aligos Therapeutics Grants Stock Options to New Hires Under 2024 Inducement Plan